| Prevention of Tuberculosis: A Review of Guidelines |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1223-000 |
| glucagon |
|
|
|
Reimbursement Review |
|
Complete |
SR0626-000 |
| Lasmiditan for the Acute Treatment of Migraine |
|
|
|
Horizon Scan |
Emerging Health Technologies |
Completed |
EH0082-000 |
| Horizon Scan Roundup — 2019 |
|
|
|
Horizon Scan |
Roundup |
Completed |
ER0008-000 |
| Oral Rehydration Solutions versus Drink of Choice in Children with Dehydration: A Review of Clinical Effectiveness |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1241-000 |
| Local Anesthetic for Urinary Catheter Insertion: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1250-000 |
| etonogestrel |
|
|
|
Reimbursement Review |
|
Withdrawn |
SR0629-000 |
| CADTH Pharmaceutical Reviews Update — Issue 14 |
|
|
|
Reimbursement Review |
Pharmaceutical Review Update |
|
|
| Botulinum Toxin for Temporomandibular Disorders: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1245-000 |
| Manual Therapy for Persistent, Non-Cancer Back and Neck Pain: A Review of Clinical Effectiveness |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1231-000 |
| Non-pharmacological and Pharmacological Intervention for Smoking Cessation Programs in Youth: A Review of Clinical Effectiveness and Guidelines |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1235-000 |
| Orthotic Bracing or Splinting of Upper Extremities in Patients with Chronic, Non-Cancer Pain: A Review of Clinical Effectiveness |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1252-000 |
| Magnetic Localization System for Sentinel Lymph Node Biopsy: A Review of the Diagnostic Accuracy, Cost-Effectiveness, and Guidelines |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1249-000 |
| Prenatal and Postnatal Home Visiting Programs for Parents, Newborns, and Babies: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1243-000 |
| Lurasidone Hydrochloride for Bipolar Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1244-000 |
| Pilocarpine for Xerostomia and Xerophthalmia in Sjögren’s Syndrome: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1227-000 |
| pembrolizumab |
|
|
|
Reimbursement Review |
|
Not filed |
NS0012-000 |
| Palivizumab For Infection Prevention in Inuit Infants: A Review of the Clinical Effectiveness and Cost-Effectiveness |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1217-000 |
| Ondansetron and Oral Rehydration Therapy in Pediatric Patients with Dehydration: Clinical Effectiveness |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1242-000 |
| Prostaglandin Analogues for Ophthalmic Use: A Review of Comparative Clinical Effectiveness, Cost-Effectiveness, and Guidelines |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1248-000 |
| Quetiapine for Major Depressive Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1233-000 |
| Combination Use of Ivabradine with Sacubitril/Valsartan: A Review of Clinical Effectiveness and Guidelines |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1247-000 |
| Intraosseous Contrast Media Injection for Computed Tomography Scan or Magnetic Resonance Imaging: A Review of Clinical Effectiveness and Guidelines |
|
|
|
Health Technology Review |
Summary with Critical Appraisal |
Completed |
RC1234-000 |
| Minimally invasive therapies for benign prostatic hyperplasia (BPH) |
|
|
|
Horizon Scan |
Emerging Health Technologies |
Completed |
EH0078-000 |
| Orilissa (elagolix) |
|
|
|
Reimbursement Review |
|
Not filed |
NS0011-000 |
